Literature DB >> 23585337

Coagulation and fibrinolytic indices during the first trimester of pregnancy in women with polycystic ovary syndrome: a preliminary study.

Yu Shan1, Aiming Wang, Ying Sun, Wen Jiang, Baosen Pang, Zhiyuan An, Xin Du, Wei Wang, Zhongwei Huang.   

Abstract

OBJECTIVE: To evaluate the levels of coagulation and fibrinolytic markers during the first trimester of pregnancy in women with polycystic ovary syndrome (PCOS) and determine the effects of PCOS and obesity on the levels of these hemostatic markers.
METHODS: A cross-sectional study was conducted in Beijing, China, on women with PCOS (n = 50), healthy women (n = 50), pregnant women with PCOS (n = 50), and healthy pregnant women (n = 50) at 12 weeks of pregnancy. Coagulation and fibrinolytic parameters were measured.
RESULTS: The interaction between PCOS and pregnancy appears to exert effects on the activities of coagulation factors VIII and X. The interaction between PCOS and obesity also seems to affect the level of von Willebrand factor.
CONCLUSIONS: Pregnant women with PCOS, especially women who are obese, are observed to be in a more prohemostatic state during the first trimester.

Entities:  

Keywords:  coagulation; fibrinolysis; obesity; polycystic ovary syndrome; pregnancy

Mesh:

Substances:

Year:  2013        PMID: 23585337      PMCID: PMC3795423          DOI: 10.1177/1933719113485293

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  30 in total

1.  Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?

Authors:  Ilse Mertens; Marc Van der Planken; Bob Corthouts; Luc F Van Gaal
Journal:  Metabolism       Date:  2006-05       Impact factor: 8.694

2.  Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss.

Authors:  Charles J Glueck; Ping Wang; Seref Bornovali; Naila Goldenberg; Luann Sieve
Journal:  Metabolism       Date:  2003-12       Impact factor: 8.694

3.  Dyslipidemias and fibrinolysis.

Authors:  Luca Puccetti; Fulvio Bruni; Anna Laura Pasqui; Marcello Pastorelli; Giovanni Bova; Michela Cercignani; Alberto Palazzuoli; Alberto Auteri
Journal:  Ital Heart J       Date:  2002-10

4.  Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.

Authors:  Franco Carmassi; Ferdinando De Negri; Roberta Fioriti; Antonio De Giorgi; Chiara Giannarelli; Franca Fruzzetti; Roberto Pedrinelli; Giulia Dell'Omo; Chiara Bersi
Journal:  Thromb Res       Date:  2005-01-01       Impact factor: 3.944

Review 5.  Haemostatic changes in pregnancy.

Authors:  Benjamin Brenner
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

6.  Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.

Authors:  I F Godsland; D Crook; A J Proudler; J C Stevenson
Journal:  J Clin Endocrinol Metab       Date:  2004-10-19       Impact factor: 5.958

7.  Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity.

Authors:  Antonia Sambola; Julio Osende; James Hathcock; Michael Degen; Yale Nemerson; Valentin Fuster; Jill Crandall; Juan Jose Badimon
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

Review 8.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

Review 9.  Vascular function, insulin resistance and fatty acids.

Authors:  H O Steinberg; A D Baron
Journal:  Diabetologia       Date:  2002-04-04       Impact factor: 10.122

10.  Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss.

Authors:  Astrid Dossenbach-Glaninger; Michael van Trotsenburg; Walter Krugluger; Martin R Dossenbach; Christian Oberkanins; Johannes Huber; Pierre Hopmeier
Journal:  Thromb Haemost       Date:  2004-04       Impact factor: 5.249

View more
  1 in total

1.  Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.

Authors:  Ying Liu; Mei-Guo Sun; Rong Jiang; Rui Ding; Zhen Che; Yan-Yan Chen; Ci-Jiang Yao; Xiao-Xia Zhu; Ji-Yu Cao
Journal:  J Assist Reprod Genet       Date:  2014-01-17       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.